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Statin use
(n=337) No statin (n=436) p-value
ACS presentation 37.7% (127) 69.7% (304) <0.0001
Angiographic
ﬁndings
Three vessel
disease
33.5% (113) 21.6% (94) 0.0002
Any calciﬁcation 46.6% (157) 38.5% (168) 0.02
IVUS ﬁndings
Minimum lumen
area (MLA), mm2
3.1 [2.9, 3.2] 2.7 [2.6, 2.8] <0.0001
www.jacctctabstracts2013.com TUESDAY, OCTOBER 29, 2013, 1:00 PM–3:15 PMold balloon angioplasty (POBA), paclitaxel-coated balloon dilatation (PCB), and
drug-eluting stent (DES) implantation.
Methods: Between July 2008 and May 2012, we performed PCI for 321 ISR lesions
using POBA (67 lesions, POBA group), PCB (149 lesions, PCB group), and DES
(105 lesions, DES group). The morphological assessment of neointimal tissue at the
minimum lumen area site as to restenotic tissue structure (homogeneous, heteroge-
neous, or layered type) using OCT was performed. We examined the association
between tissue structure and mid-term (6-8 months) results including ISR and target
lesion revascularization (TLR) rates.
Results: The patients were 263 men and 58 women, and the mean age was 68.99.6
years. The mean follow-up period was 20938 days. The association of tissue
structure with ISR and TLR rates in each groups is shown in the ﬁgure. The ISR rates
of lesions with homogeneous and layered structure were signiﬁcantly lower in the
PCB and DES groups than in the POBA group, whereas there were no differences
between 3 groups in heterogeneous structure.Plaque volume, % 56.1 [55.2, 57.1] 58.1 [57.3, 58.9] 0.003
Dense calcium
volume, %
11.8 [11.0, 12.7] 9.5 [8.9, 10.1] <0.0001
Plaque rupture 26.6 % (107) 38.4% (197) 0.0002
TCFA at MLA site 10.7% (43) 14.2% (73) 0.12
Any lesion TCFA 45.2% (182) 56.1% (288) 0.001
Calciﬁed-ThCFA at
MLA site
24.6% (99) 15.8% (81) 0.0008
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SConclusions: The morphological assessment of ISR tissue using OCT might suggest
favorable types of PCI for ISR lesions.
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Background: Previous IVUS studies, due to small size, were not able to establish
a relation between statin use and its impact on plaque composition by grayscale and
VH-IVUS.
Methods: ADAPT-DES was a prospective multicenter study of 8,583 pts undergoing
percutaneous coronary intervention (PCI) using drug-eluting stents. A pre-speciﬁed
grayscale and VH-IVUS sub-study enrolled 2,064 pts. Pre-PCI imaging of 773 pts
identiﬁed 907 culprit lesions. Pts with vs without statin use prior to hospital admission
were compared.
Results: Overall, 43.6% (377) of pts were treated with statins prior to admission. Pts
using statins were older and had a higher prevalence of risk factors such as diabetes
(33% vs 20%, p<0.0001), hypertension (90% vs 59%, p¼0.02), and renal insufﬁ-
ciency (creatinine clearance <60 ml/min, 14% vs 7%, p¼0.001). At admission, statin
pts were frequently taking medications such as aspirin, ACEI/ARB, and beta-blockers
(all p<0.0001). Statin pts were more likely to present with more stable angina, while
non-statin pts more frequently presented with ST-segment elevation (STE) and non-
STE acute coronary syndromes (Table). Statin pts were more likely to have angio-
graphic 3-vessel disease and calciﬁcation. Grayscale and VH-IVUS ﬁndings showed
that statin pts had slightly larger minimum lumen area (MLA) along with less plaque
burden, but with more dense calcium (DC). Statin pts had more calciﬁed thick-cap
ﬁbroatheromas (ThCFA: necrotic core >10%, conﬂuent DC >10%, well-deﬁned
ﬁbrous cap), but fewer thin-cap ﬁbroatheromas (TCFAs) or plaque ruptures.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrConclusions: Chronic statin use in PCI patients was associated with more stable
clinical presentation and IVUS ﬁndings consistent with greater lesion stability (fewer
VH-TCFAs and plaque ruptures, more ThCFAs) compared to pts with CAD who were
not taking statins.
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Background: Chronic total occlusions of the vessels in the periphery are often
encountered and present signiﬁcant technical challenges. The presence of occlusive
disease is associated with higher rates of failed re-canalization and worse long term
results. Currently, subintimal dissection and re-entry techniques are commonly
used to treat these challenging lesions. For all subsequent therapy, including
angioplasty, stenting and atherectomy, the ability to cross occlusions while staying
within the true lumen is preferred. Devices and techniques which allow re-
canalization through the true lumen represent an important and unmet clinical need.
Forward-looking IVUS (FL.IVUS) is a new technology that has been developed to
provide real-time therapy guidance while crossing challenging peripheral
occlusions.
Methods: A non-randomized, non-blinded, multi-center, ﬁrst-in-man, four-phase,
prospective study was performed to assess the safety and feasibility of the Forward-
looking IVUS system in subjects with peripheral artery disease undergoing endo-
vascular therapy. In the fourth phase of this study, the FL.IVUS device was used to
provide real-time guidance while crossing CTOs in iliac and femoral vessels.
Results: Twenty cases were completed at three centers to assess the safety and
feasibility of the Forward-looking IVUS system in crossing peripheral chronic total
occlusions. The FL.IVUS catheter provided real-time images of the vessel and
occlusion. These images were used for guidewire placement and to conﬁrm true lumen
position while crossing the CTOs. Two cases from the ﬁrst-in-human series will be
presented to highlight the clinical utility and imaging performance of the FL.IVUS
system.
Conclusions: A novel Forward-looking IVUS device was used to provide real-time,
intraluminal guidance for the treatment of CTOs in the iliac and femoral arteries. This
ﬁrst-in-human clinical series demonstrates the preliminary safety and feasibility of this
novel imaging modality for the endovascular treatment of complex peripheral artery
disease. Future directions for the technology include improved catheter performance
and new imaging and software features.acts/ORAL/Invasive Imaging B23
